It is a pharma private limited company based in Jammu, Jammu & Kashmir, India, established in 2015.
2015 | Jammu, Jammu & Kashmir, India | ActiveBaldwin Pharmaceuticals Private Limited, a active private limited company, was established on 22 September 2015 in Jammu, Jammu & Kashmir, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U52100JK2015PTC004504. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹0.80 M and a paid-up capital of ₹0.80 M.
It upholds a compliant status. Its leadership includes Preeti Gupta (Director), Vipen Kumar Mahajan (Director), Simranjeet Singh (Director). Past directors included Sahil Mahajan. It holds ₹4.00 M open charges and ₹1.10 M settled loans. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at H No 105, Lano No 16, Talab Tillo Jammu (J&K), Jammu, Jammu & Kashmir, 180002.
U52100JK2015PTC004504
004504
22 September 2015
₹0.80 M
₹0.80 M
Roc Jammu
Unlisted
Active
Explore comprehensive insights into Baldwin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Preeti Gupta | Director | 22 Sep 2015 | Current |
| Vipen Kumar Mahajan | Director | 22 Sep 2015 | Current |
| Simranjeet Singh | Director | 22 Sep 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 01 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Baldwin Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 38.56% decrease. The company also saw a substantial improvement in profitability, with a 46.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 91.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Baldwin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹1,100,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 May 2016 | Others | ₹4.00 M | Open |
| 19 Jan 2016 | The Jammu And Kashmir Bank Limited | ₹1.10 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Baldwin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Baldwin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baldwin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Baldwin Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
The activity Baldwin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Jammu. was completed.
Progress on A charge registered on 19 Jan 2016 via Charge ID 10614595 with The Jammu And Kashmir Bank Limited was fully satisfied on 04 Jun 2016. was documented.
The activity A charge with Others amounted to Rs. 4.00 M with Charge ID 100034359 was registered on 28 May 2016. was completed.
The activity A charge with The Jammu And Kashmir Bank Limited amounted to Rs. 1.10 M with Charge ID 10614595 was registered on 19 Jan 2016. was completed.
Preeti Gupta was appointed as a Director was appointed as a Director on 22 Sep 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.
The CIN of Baldwin Pharmaceuticals Private Limited is U52100JK2015PTC004504.
Baldwin Pharmaceuticals Private Limited is headquartered at H No 105, Lano No 16, Talab Tillo Jammu (J&K), Jammu, Jammu & Kashmir, 180002.
Baldwin Pharmaceuticals Private Limited was incorporated on 22 September 2015.
The current directors of Baldwin Pharmaceuticals Private Limited are
The primary industry of Baldwin Pharmaceuticals Private Limited is Trade.
Baldwin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Baldwin Pharmaceuticals Private Limited is ₹0.80 M, and the paid-up capital is ₹0.80 M.
The compliance status of Baldwin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX